Tempest Therapeutics | DEF 14A: Definitive information statements
Apr 23 16:07 ET
Tempest Therapeutics | DEFA14A: Others
Apr 23 16:06 ET
Tempest Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 19 17:08 ET
Tempest Therapeutics | 8-K: Current report
Mar 19 16:12 ET
Tempest Therapeutics | S-8 POS: S-8 POS
Nov 17, 2023 16:46 ET
Tempest Therapeutics | S-8 POS: S-8 POS
Nov 17, 2023 16:45 ET
Tempest Therapeutics | S-8 POS: S-8 POS
Nov 17, 2023 16:44 ET
Tempest Therapeutics | S-8 POS: S-8 POS
Nov 17, 2023 16:44 ET
Tempest Therapeutics | S-8 POS: S-8 POS
Nov 17, 2023 16:43 ET
Tempest Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Nov 17, 2023 16:39 ET
Tempest Therapeutics | 8-K: Tempest Reports Third Quarter 2023 Financial Results and Provides Business Update
Nov 8, 2023 17:18 ET
Tempest Therapeutics | 8-K: Current report
Oct 30, 2023 06:06 ET
Tempest Therapeutics | 8-K: Current report
Oct 11, 2023 08:13 ET
Tempest Therapeutics | 8-K: Current report
Sep 8, 2023 16:16 ET
Tempest Therapeutics | 8-K: Current report
Sep 7, 2023 16:19 ET
Tempest Therapeutics | 8-K: Tempest Reports Second Quarter 2023 Financial Results and Provides Business Update
Aug 10, 2023 16:27 ET
Tempest Therapeutics | 8-K: Current report
Jun 16, 2023 16:22 ET
Tempest Therapeutics | 8-K: Tempest Reports First Quarter 2023 Financial Results and Provides Business Update
May 10, 2023 16:21 ET
Tempest Therapeutics | DEFA14A: Others
May 1, 2023 16:11 ET
Tempest Therapeutics | DEF 14A: Definitive proxy statements
May 1, 2023 16:07 ET
No Data
No Data